Ceftaroline Fosamil for the Treatment of Community-Acquired Pneumonia: from FOCUS to CAPTURE

Ceftaroline fosamil (ceftaroline hereafter) is the latest addition to the armamentarium for the treatment of patients with community-acquired pneumonia (CAP). It is currently approved by the Food and Drug Administration (FDA) for community-acquired bacterial pneumonia (CABP), which is a recent FDA i...

Descripción completa

Detalles Bibliográficos
Autores principales: Carreno, Joseph J., Lodise, Thomas P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269637/
https://www.ncbi.nlm.nih.gov/pubmed/25193094
http://dx.doi.org/10.1007/s40121-014-0036-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269637/
https://www.ncbi.nlm.nih.gov/pubmed/25193094
http://dx.doi.org/10.1007/s40121-014-0036-8

Ejemplares similares